RetractedTrialThe New England journal of medicine2017
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
Gunter von Minckwitz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
645 papers cite itlatest 60 shown
this paperpooled ittrialcites it